Last update :
18/04/2024
Anticancer drug   Temozolomide  
Oral solution
Injection
Stability of pharmaceutical preparations Stability of mixtures Factors which affect stability Compatibility References Pdf
   Chemical structure  

Oral solution
Stability of pharmaceutical preparations   Oral solution   Stability of pharmaceutical preparations : Temozolomide     
Container Origine Excipient Temperature Storage Duration of stability References
Glass Kapseln 150 mg
Temodal®
Oral Mix SF® >> 15 mL
2-8°C Protect from light
56 Day
4397

Plastic bottle Kapseln 150 mg
Temodal®
Oral Mix SF® >> 15 mL
2-8°C Protect from light
56 Day
4397

Plastic bottle Kapseln 300 mg
Temodar®
Povidone K30 150 mg
Citric acid anhydrous 7.5 mg
Purified water 0.45 ml
OraPlus® 15 ml
Orasweet® >> 30 ml
4°C Protect from light
60 Day
2855

Plastic bottle Kapseln 300 mg
Temodar®
Povidone K30 150 mg
Citric acid anhydrous 7.5 mg
Purified water 0.45 ml
OraPlus® 15 ml
Orasweet SF ® >> 30 ml
4°C Protect from light
60 Day
2855

Syringe Kapseln 10 mg
Temodal®
Oral Mix SF® >> 1 mL
2-8°C Protect from light
56 Day
4397


  Mentions Légales